{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:27:24Z","timestamp":1791034044657,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"21-22","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.drudis.2009.07.010","type":"journal-article","created":{"date-parts":[[2009,8,7]],"date-time":"2009-08-07T05:54:34Z","timestamp":1249624474000},"page":"1067-1074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":135,"title":["Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation"],"prefix":"10.1016","volume":"14","author":[{"given":"Tripta","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Jaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roop K.","family":"Khar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushama","family":"Talegaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2009.07.010_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18433\/J3RC77","article-title":"Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy","volume":"12","author":"Bansal","year":"2009","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.addr.2007.08.017","article-title":"The effects of pharmaceutical excipients on drug disposition","volume":"59","author":"Buggins","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2009.07.010_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02976620","article-title":"Recent progress in drug delivery systems for anticancer agents","volume":"25","author":"Kim","year":"2002","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.drudis.2009.07.010_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2008.07.034","article-title":"Development of chitosan-SLN microparticles for chemotherapy: in vitro approach through efflux-transporter modulation","volume":"131","author":"Dharmala","year":"2008","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/jps.20100","article-title":"Development of solid lipid nanoparticles containing ionically complexed chemotherapeutic drugs and chemosensitizers","volume":"93","author":"Wong","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles","volume":"59","author":"Wong","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2009.07.010_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0928-0987(00)00114-7","article-title":"Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2006.02.018","article-title":"Polyethylene glycol-phosphatidylethanolamine conjugate (PEG\u2013PE)-based mixed micelles: some properties, loading with paclitaxel, and modulation of P-glycoprotein-mediated efflux","volume":"315","author":"Dabholkar","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijpharm.2006.08.039","article-title":"Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells","volume":"329","author":"Kobayashi","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.urolonc.2007.03.015","article-title":"Nanoparticles for drug delivery in cancer treatment","volume":"26","author":"Haley","year":"2008","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.drudis.2009.07.010_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-3659(03)00163-9","article-title":"Relationships between the hydrophilic\u2013lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines","volume":"90","author":"Lo","year":"2003","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib13","first-page":"319","article-title":"Lipid excipients Peceol and Gelucire 44\/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells","volume":"10","author":"Sachs-Barrable","year":"2007","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2004.03.001","article-title":"Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo","volume":"278","author":"Cornaire","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib15","first-page":"1195","article-title":"Potentiation of drug effect by Tween 80 in Chinese hamster cells resistant to actinomycin D and daunomycin","volume":"32","author":"Riehm","year":"1972","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2009.07.010_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1992.217","article-title":"Reversal of multidrug resistance by surfactants","volume":"66","author":"Woodcock","year":"1992","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drudis.2009.07.010_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0928-0987(02)00055-6","article-title":"Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers","volume":"16","author":"Rege","year":"2002","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejps.2005.04.003","article-title":"Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo","volume":"25","author":"Varma","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2008.11.021","article-title":"Inhibiting efflux with novel non-ionic surfactants: rational design based on vitamin E TPGS","volume":"370","author":"Wempe","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2009.05.001","article-title":"Effects of polyoxyethylene (40) stearate on the activity of P-glycoprotein and cytochrome P450","author":"Zhu","year":"2009","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2005.11.005","article-title":"Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers","volume":"111","author":"Collnot","year":"2006","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib22","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ijpharm.2008.04.013","article-title":"Enhanced oral bioavailability of paclitaxel by D-alpha-tocopheryl polyethylene glycol 400 succinate in mice","volume":"359","author":"Ho","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib23","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1023\/A:1011964213024","article-title":"Effects of Pluronic block copolymers on drug absorption in Caco-2 cell monolayers","volume":"15","author":"Batrakova","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2009.07.010_bib24","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/j.biomaterials.2006.03.033","article-title":"In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan","volume":"27","author":"Foger","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2009.07.010_bib25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00137696-200604040-00008","article-title":"Polymeric efflux pump inhibitors in oral drug delivery","volume":"4","author":"Bernkop-Schn\u00fcrch","year":"2006","journal-title":"Am. J. Drug Deliv."},{"key":"10.1016\/j.drudis.2009.07.010_bib26","unstructured":"Carreno-Gomez, B. and Duncan, R. (2002) Compositions with enhanced oral bioavailability (vol. USP 20030211072)"},{"key":"10.1016\/j.drudis.2009.07.010_bib27","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11095-007-9347-8","article-title":"Natural and synthetic polymers as inhibitors of drug efflux pumps","volume":"25","author":"Werle","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2009.07.010_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijpharm.2006.01.020","article-title":"Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies","volume":"313","author":"Shen","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib29","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jconrel.2003.12.006","article-title":"The use of a dendrimer-propranolol prodrug to bypass efflux transporters and enhance oral bioavailability","volume":"95","author":"D\u2019Emanuele","year":"2004","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jconrel.2005.11.011","article-title":"Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine","volume":"111","author":"Werle","year":"2006","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib31","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jconrel.2008.01.018","article-title":"Polymeric micelles in oral chemotherapy","volume":"128","author":"Bromberg","year":"2008","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib32","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/jps.21479","article-title":"Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function","volume":"98","author":"Elamanchili","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2008.08.021","article-title":"Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug","volume":"133","author":"Nassar","year":"2009","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ijpharm.2006.03.045","article-title":"Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux","volume":"320","author":"Chavanpatil","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib35","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1021\/mp070024d","article-title":"Surfactant-polymer nanoparticles overcome P-glycoprotein-mediated drug efflux","volume":"4","author":"Chavanpatil","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0927-7765(99)00080-6","article-title":"Poly(ethylene glycol)\u2013polyethyleneimine NanoGel\u2122 particles: novel drug delivery systems for antisense oligonucleotides","volume":"16","author":"Vinogradov","year":"1999","journal-title":"Colloids Surf. B: Biointerf."},{"key":"10.1016\/j.drudis.2009.07.010_bib37","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0927-7765(99)00064-8","article-title":"Block copolymer-based formulation of doxorubicin from cell screen to clinical trials","volume":"16","author":"Alakhov","year":"1999","journal-title":"Colloids Surf. B: Biointerf."},{"key":"10.1016\/j.drudis.2009.07.010_bib38","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/sj.bjc.6601856","article-title":"Phase I dose escalation and pharmacokinetic study of Pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer","volume":"90","author":"Danson","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.drudis.2009.07.010_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0959-8049(98)00373-6","article-title":"A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier","volume":"35","author":"St\u2019astny","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.drudis.2009.07.010_bib40","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0168-3659(02)00419-4","article-title":"Effects of polyether-modified poly(acrylic acid) microgels on doxorubicin transport in human intestinal epithelial Caco-2 cell layers","volume":"88","author":"Bromberg","year":"2003","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1211\/0022357011776126","article-title":"Triton-X-100-modified polymer and microspheres for reversal of multidrug resistance","volume":"53","author":"Liu","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drudis.2009.07.010_bib42","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jconrel.2006.02.014","article-title":"Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition","volume":"112","author":"Lamprecht","year":"2006","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jconrel.2006.03.001","article-title":"In vivo efficacy of novel paclitaxel nanoparticles in paclitaxel-resistant human colorectal tumors","volume":"112","author":"Koziara","year":"2006","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1023\/B:PHAM.0000016238.44452.f1","article-title":"Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors","volume":"21","author":"Yang","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2009.07.010_bib45","article-title":"Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies","author":"Nornoo","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-3659(01)00406-0","article-title":"Effect of PSC 833 liposomes and Intralipid on the transport of epirubicin in Caco-2 cells and rat intestines","volume":"76","author":"Lo","year":"2001","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ijpharm.2007.11.030","article-title":"The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats","volume":"353","author":"Dadashzadeh","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1368-7646(03)00082-7","article-title":"Liposome-based approaches to overcome anticancer drug resistance","volume":"6","author":"Mamot","year":"2003","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.drudis.2009.07.010_bib49","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jconrel.2006.09.007","article-title":"Simultaneous delivery of doxorubicin and GG918 (Elacridar) by new polymer\u2013lipid hybrid nanoparticles (PLN) for enhanced treatment of multidrug-resistant breast cancer","volume":"116","author":"Wong","year":"2006","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib50","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1016\/j.biomaterials.2006.08.004","article-title":"In vivo comparison of various polymeric and low molecular mass inhibitors of intestinal P-glycoprotein","volume":"27","author":"Foger","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2009.07.010_bib51","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1002\/jps.10176","article-title":"A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro","volume":"91","author":"Hugger","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib52","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1248\/bpb.30.1301","article-title":"Effects of Labrasol and other pharmaceutical excipients on the intestinal transport and absorption of rhodamine123, a P-glycoprotein substrate, in rats","volume":"30","author":"Lin","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.drudis.2009.07.010_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/jps.20017","article-title":"Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes","volume":"93","author":"Shono","year":"2004","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2009.07.010_bib54","first-page":"5994","article-title":"Effects of nonionic detergents on P-glycoprotein drug binding and reversal of multidrug resistance","volume":"53","author":"Zordan-Nudo","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.drudis.2009.07.010_bib55","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jconrel.2005.06.002","article-title":"Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs","volume":"107","author":"Vinogradov","year":"2005","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib56","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.biomaterials.2006.03.006","article-title":"The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles","volume":"27","author":"Zhang","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2009.07.010_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2009.01.021","article-title":"Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance","volume":"136","author":"Patil","year":"2009","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib58","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijpharm.2006.06.013","article-title":"Self-assembled nanoparticles of poly(lactide)\u2014vitamin E TPGS copolymers for oral chemotherapy","volume":"324","author":"Zhang","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0300-483X(99)00206-1","article-title":"Modulation of daunorubicin toxicity by liposomal encapsulation and use of specific inhibitors in vitro","volume":"144","author":"Iffert","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.drudis.2009.07.010_bib60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0168-3659(03)00271-2","article-title":"Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel","volume":"91","author":"Immordino","year":"2003","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib61","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijpharm.2005.07.028","article-title":"Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization","volume":"314","author":"Elkharraz","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib62","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0168-3659(02)00047-0","article-title":"HPMA-hydrogels containing cytostatic drugs. Kinetics of the drug release and in vivo efficacy","volume":"81","author":"St\u2019astny","year":"2002","journal-title":"J. Control Rel."},{"key":"10.1016\/j.drudis.2009.07.010_bib63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11095-006-9171-6","article-title":"Paclitaxel-2\u2019-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity","volume":"24","author":"Tanino","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.drudis.2009.07.010_bib64","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1038\/sj.onc.1207463","article-title":"Prodrug chemotherapeutics bypass P-glycoprotein resistance and kill tumors in vivo with high efficacy and target-dependent selectivity","volume":"23","author":"Guillemard","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.drudis.2009.07.010_bib65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2004.05.014","article-title":"Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats","volume":"280","author":"Choi","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2009.07.010_bib66","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jconrel.2006.10.007","article-title":"Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors","volume":"117","author":"Ho","year":"2007","journal-title":"J. Control Rel."}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609002542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644609002542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:05:53Z","timestamp":1761221153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644609002542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":66,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S1359644609002542"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2009.07.010","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2009.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}